Ushbu ishga iqtibos qilgan ishlar

2 ta ish

Ish: Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells

1. RETRACTED: The pathogenicity of COVID-19 and the role of pentraxin-3: An updated review study

   Ria Margiana, Satish Kumar Sharma, Bilal Irshad Khan +7

   MaqolaBiomarkers in Disease MechanismsPathology - Research and Practice20220 iqtibos

   ABIABI:AkademIndex/openalex/2022.article.001050

2. Immunotherapy of inflammatory bowel disease (IBD) through mesenchymal stem cells

   Huldani Huldani, Ria Margiana, Fawad Ahmad +5

   Sharh maqolaMesenchymal stem cell researchInternational Immunopharmacology20220 iqtibos

   ABIABI:AkademIndex/openalex/2022.review-article.000013